Is it safe? · Pregnancy Smart
Umbilical artery Doppler ultrasound in pregnancy
What does the evidence say about umbilical artery doppler ultrasound during pregnancy?
- SMFM recommends serial umbilical artery Doppler after fetal growth restriction is identified. It suggests weekly assessment for severe growth restriction or decreased diastolic velocity, two to three assessments per week for absent end-diastolic velocity, and hospital-level surveillance when flow is reversed. 1
- SMFM links delivery timing to the whole fetal-growth-restriction picture: 37 weeks for decreased diastolic flow without absent or reversed flow, 33 to 34 weeks for absent flow, and 30 to 32 weeks for reversed flow. These are specialist recommendations, not rules based on a single home reading. 1
- An updated Cochrane review of 19 trials involving 10,667 high-risk pregnancies associated fetal or umbilical Doppler use with lower perinatal mortality and fewer inductions and cesareans than no Doppler. Trial quality and protocol heterogeneity limited certainty, and the intervention included broader surveillance rather than one isolated measurement. 2
- A systematic review of 42 studies and 18,282 low-risk or unselected pregnancies found absent or reversed end-diastolic flow was rare and reported in only six studies. Most evidence was observational and from higher-income settings, so it did not establish benefit from routine Doppler screening in low-risk pregnancies. 3
- A reference study performed serial measurements in 590 uncomplicated pregnancies from 14 to 42 weeks and showed that Doppler ratios depend on gestational age. Its historical healthy cohort supplied normal ranges, not outcome evidence or a threshold that patients can interpret without clinical context. 4
Is umbilical artery doppler ultrasound safe in each trimester?
- First trimester. Umbilical artery Doppler is not a routine first-trimester reassurance scan. If very early growth concerns arise, the clinician first confirms dating, anatomy, and possible maternal, fetal, or placental causes before deciding which surveillance is informative.
- Second trimester. Early-onset fetal growth restriction before 32 weeks often prompts detailed ultrasound and specialist evaluation. Doppler values must be interpreted against gestational age because normal resistance indices change as pregnancy advances.
- Third trimester. Serial umbilical artery Doppler is most commonly used once growth restriction is established. Normal, decreased, absent, and reversed diastolic-flow patterns lead to different surveillance frequency and delivery discussions based on the full clinical picture.
Frequently asked questions
What does an umbilical artery Doppler measure?
Umbilical artery Doppler records the cord artery's blood-flow waveform and calculates resistance-related indices. Clinicians use the pattern as an indirect marker of placental resistance and fetal condition, interpreted with gestational age, fetal size, amniotic fluid, and other surveillance results.
Why is umbilical artery Doppler used for fetal growth restriction?
Growth restriction can reflect placental insufficiency. Umbilical artery Doppler helps distinguish concerning placental resistance from a constitutionally small fetus and can show deterioration over time, which is why SMFM recommends serial assessment after growth restriction is identified.
What does absent end-diastolic flow mean?
Absent end-diastolic flow means forward blood flow is not detected in the resting phase between heartbeats. In fetal growth restriction, SMFM considers this a significant abnormality that warrants Doppler assessment up to two or three times weekly plus additional fetal surveillance.
What does reversed end-diastolic flow mean?
Reversed end-diastolic flow means the resting-phase component moves in the opposite direction. SMFM advises hospitalization, antenatal corticosteroids when appropriate, frequent fetal-heart surveillance, and delivery planning based on gestational age and the complete clinical picture.
How often is umbilical artery Doppler repeated?
Frequency depends on fetal size and the waveform. SMFM suggests weekly checks for severe growth restriction or decreased diastolic flow, up to two or three checks weekly for absent flow, and more intensive hospital surveillance for reversed flow.
Does an abnormal Doppler result mean immediate delivery?
Not automatically. Gestational age, whether flow is decreased, absent, or reversed, fetal-heart testing, growth, amniotic fluid, maternal conditions, and available neonatal support all shape the plan. Reversed flow usually prompts hospitalization and an earlier delivery discussion.
Is umbilical artery Doppler useful in every low-risk pregnancy?
Routine benefit has not been established for every low-risk pregnancy. Absent or reversed flow is rare in low-risk cohorts, and evidence supporting Doppler is strongest in pregnancies already considered high risk, particularly those with fetal growth restriction.
Is this the same as a home fetal-heart Doppler?
No. Umbilical artery Doppler ultrasound is performed and interpreted by trained clinicians to analyze a blood-flow waveform. A home fetal-heart device only attempts to detect a heartbeat and cannot assess placental resistance, fetal growth, or absent or reversed diastolic flow.
Related in the library
Symptoms
Fetal growth restriction
Symptoms
Marginal cord insertion
Symptoms
Velamentous cord insertion
Symptoms
Two-vessel umbilical cord
Is it safe?
When Do Nonstress Tests and Biophysical Profiles Start?
Comparisons
Twin Pregnancy Growth Scan Schedule by Chorionicity
Is it safe?
Is CT contrast safe while breastfeeding?
References
PubMed / Society for Maternal-Fetal Medicine · https://pubmed.ncbi.nlm.nih.gov/32407785/
Fetal and umbilical Doppler ultrasound in high-risk pregnancies
PMC / Cochrane · https://pmc.ncbi.nlm.nih.gov/articles/PMC6481396/
PMC · https://pmc.ncbi.nlm.nih.gov/articles/PMC7881445/
Doppler umbilical artery waveform indices--normal values from fourteen to forty-two weeks
PubMed · https://pubmed.ncbi.nlm.nih.gov/2675607/
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
